RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
RNTX
36 hedge funds and large institutions have $9.54M invested in Rein Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
9
Reduced
5
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VC
Voss Capital
Houston,
Texas
|
+$620K |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$234K |
3 |
Citadel Advisors
Miami,
Florida
|
+$67.2K |
4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$46.5K |
5 |
GG
Gleason Group
Prospect,
Kentucky
|
+$31.3K |
Top Sellers
1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$101K |
2 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$39.8K |
3 |
TSS
Two Sigma Securities
New York
|
-$28.8K |
4 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$19.8K |
5 |
Morgan Stanley
New York
|
-$7.61K |